Dr. Reddy’s Recalls Acne Medication From U.S. Market

☞ | View the text of this post. Exclusively available to ASQ Members.

City-based pharma giant Dr. Reddy’s Laboratories (DRL) has voluntarily recalled 13,221 cartons of Zenatane capsules, which is used to treat severe cystic acne, from the U.S. market.

Citing the reason for the recall, the company said the drug failed “dissolution specifications out of specification results observed for low dissolution.” The drug was being manufactured by Cipla Limited’s unit at Kurkumbh for DRL. The recall falls under ‘Class II’, which is defined by the U.S. Food and

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *